Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Sphingosine-1-phosphate (S1P) receptors are crucial in the central nervous system, regulating glia cell function.
• Fingolimod (FTY720), phosphorylated to FTY720P, targets multiple S1P receptors and is in clinical trials for multiple sclerosis.

Purpose of the Study:

• To identify the specific central nervous system cell types and S1P receptors targeted by FTY720P.
• To elucidate the signaling pathways and cellular responses mediated by FTY720P in astrocytes.

Main Methods:

• Calcium imaging in mixed embryonic rat cortical cultures to assess cellular responses.
• Analysis of S1P receptor expression (S1P1, S1P3) in enriched astrocyte cultures.
• Gi protein-mediated signaling cascade activation assays.
• Astrocyte migration assays using FTY720P and S1P1-selective agonist SEW2871.

Main Results:

• Astrocytes were identified as the major cell type responsive to FTY720P in cortical cultures.
• FTY720P activates Gi protein-mediated signaling cascades in astrocytes expressing S1P1 and S1P3 receptors.
• Both FTY720P and the S1P1-selective agonist stimulated astrocyte migration.
• FTY720P primarily activates S1P1 receptors on astrocytes, while S1P activates both S1P1 and S1P3 receptors.

Conclusions:

• FTY720P predominantly targets astrocytes in the central nervous system via S1P1 receptor activation.
• The distinct S1P receptor pharmacology of FTY720P compared to S1P may underlie its therapeutic benefits in multiple sclerosis.
• Understanding FTY720P's astrocyte-specific actions provides insight into its mechanism of action for treating neurological disorders.